国产午夜福利片1000无码丨人妻国产成人久久av免费高清丨午夜做受视频试看6次丨日韩av不卡一区在线免费观看丨在线观看精品三级欧美

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Corynebacterium aurimucosum Enolase (eno) CSB-YP503643DWX
CSB-EP503643DWX
CSB-BP503643DWX
CSB-MP503643DWX
CSB-EP503643DWX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Corynebacterium aurimucosum Pantothenate kinase (coaA) CSB-YP503644DWX
CSB-EP503644DWX
CSB-BP503644DWX
CSB-MP503644DWX
CSB-EP503644DWX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Corynebacterium aurimucosum Exodeoxyribonuclease 7 small subunit (xseB) CSB-YP503645DWX
CSB-EP503645DWX
CSB-BP503645DWX
CSB-MP503645DWX
CSB-EP503645DWX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Corynebacterium aurimucosum Zinc transporter ZupT (zupT), partial CSB-YP503646DWX
CSB-EP503646DWX
CSB-BP503646DWX
CSB-MP503646DWX
CSB-EP503646DWX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Corynebacterium aurimucosum Glucose-1-phosphate adenylyltransferase (glgC) CSB-YP503647DWX
CSB-EP503647DWX
CSB-BP503647DWX
CSB-MP503647DWX
CSB-EP503647DWX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Corynebacterium aurimucosum Arginine--tRNA ligase (argS), partial CSB-YP503648DWX
CSB-EP503648DWX
CSB-BP503648DWX
CSB-MP503648DWX
CSB-EP503648DWX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Corynebacterium aurimucosum Homoserine kinase (thrB) CSB-YP503649DWX
CSB-EP503649DWX
CSB-BP503649DWX
CSB-MP503649DWX
CSB-EP503649DWX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Corynebacterium aurimucosum ATP synthase epsilon chain (atpC) CSB-YP503650DWX
CSB-EP503650DWX
CSB-BP503650DWX
CSB-MP503650DWX
CSB-EP503650DWX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Corynebacterium aurimucosum UPF0286 protein cauri_1077 (cauri_1077) CSB-YP503651DWX
CSB-EP503651DWX
CSB-BP503651DWX
CSB-MP503651DWX
CSB-EP503651DWX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Corynebacterium aurimucosum tRNA-specific 2-thiouridylase mnmA (mnmA) CSB-YP503652DWX
CSB-EP503652DWX
CSB-BP503652DWX
CSB-MP503652DWX
CSB-EP503652DWX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Corynebacterium aurimucosum DNA ligase (ligA), partial CSB-YP503653DWX
CSB-EP503653DWX
CSB-BP503653DWX
CSB-MP503653DWX
CSB-EP503653DWX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Corynebacterium aurimucosum Aspartyl/glutamyl-tRNA (Asn/Gln) amidotransferase subunit C CSB-YP503654DWX
CSB-EP503654DWX
CSB-BP503654DWX
CSB-MP503654DWX
CSB-EP503654DWX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Corynebacterium aurimucosum Dihydroxy-acid dehydratase (ilvD), partial CSB-YP503655DWX
CSB-EP503655DWX
CSB-BP503655DWX
CSB-MP503655DWX
CSB-EP503655DWX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Corynebacterium aurimucosum Ketol-acid reductoisomerase (ilvC) CSB-YP503656DWX
CSB-EP503656DWX
CSB-BP503656DWX
CSB-MP503656DWX
CSB-EP503656DWX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Corynebacterium aurimucosum 3-isopropylmalate dehydrogenase (leuB) CSB-YP503657DWX
CSB-EP503657DWX
CSB-BP503657DWX
CSB-MP503657DWX
CSB-EP503657DWX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Corynebacterium aurimucosum 3-isopropylmalate dehydratase small subunit (leuD) CSB-YP503658DWX
CSB-EP503658DWX
CSB-BP503658DWX
CSB-MP503658DWX
CSB-EP503658DWX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Corynebacterium aurimucosum Glycerol-3-phosphate dehydrogenase [NAD (P)+] CSB-YP503659DWX
CSB-EP503659DWX
CSB-BP503659DWX
CSB-MP503659DWX
CSB-EP503659DWX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Corynebacterium aurimucosum D-alanine--D-alanine ligase (ddl) CSB-YP503660DWX
CSB-EP503660DWX
CSB-BP503660DWX
CSB-MP503660DWX
CSB-EP503660DWX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Corynebacterium aurimucosum Aspartate carbamoyltransferase (pyrB) CSB-YP503661DWX
CSB-EP503661DWX
CSB-BP503661DWX
CSB-MP503661DWX
CSB-EP503661DWX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Corynebacterium aurimucosum S-adenosylmethionine synthase (metK) CSB-YP503662DWX
CSB-EP503662DWX
CSB-BP503662DWX
CSB-MP503662DWX
CSB-EP503662DWX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.jhhuazhong.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>